Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cancers|September 10, 2021
Playing on the Dark Side: SMYD3 Acts as a Cancer Genome Keeper in Gastrointestinal MalignanciesPaola Sanese, Candida Fasano, Cristiano Simone
Cancers|October 28, 2023
Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic OpportunitiesKatia De Marco, Paola Sanese, Cristiano Simone, et al.
Computational and Structural Biotechnology Journal|July 16, 2019
FOXO3 on the Road to Longevity: Lessons From SNPs and Chromatin HubsPaola Sanese, Giovanna Forte, Vittoria Disciglio, et al.
Cancers|March 27, 2019
Chasing the FOXO3: Insights into Its New Mitochondrial Lair in Colorectal Cancer LandscapeValentina Grossi, Candida Fasano, Valentina Celestini, et al.
Computational and Structural Biotechnology Journal|May 2, 2022
Identifying novel SMYD3 interactors on the trail of cancer hallmarksCandida Fasano, Martina Lepore Signorile, Katia De Marco, et al.
Cells|August 28, 2024
In Silico Deciphering of the Potential Impact of Variants of Uncertain Significance in Hereditary Colorectal Cancer SyndromesCandida Fasano, Martina Lepore Signorile, Katia De Marco, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 26, 2024
Methyltransferases in cancer drug resistance: Unlocking the potential of targeting SMYD3 to sensitize cancer cellsPaola Sanese, Candida Fasano, Martina Lepore Signorile, et al.
Genes|March 6, 2021
<i>APC</i> Splicing Mutations Leading to In-Frame Exon 12 or Exon 13 Skipping Are Rare Events in FAP Pathogenesis and Define the Clinical OutcomeVittoria Disciglio, Giovanna Forte, Candida Fasano, et al.
Cell & Bioscience|December 2, 2023
Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC modelsMartina Lepore Signorile, Candida Fasano, Giovanna Forte, et al.
Computational and Structural Biotechnology Journal|November 13, 2023
The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging 'nonmutational epigenetic reprogramming' cancer hallmarkCandida Fasano, Martina Lepore Signorile, Elisabetta Di Nicola, et al.
Pageof 4